首页> 外文学位 >Generation and characterization of fine and stable powders suitable for pulmonary drug delivery using carbon dioxide-assisted nebulization with a Bubble Dryer (CAN-BD).
【24h】

Generation and characterization of fine and stable powders suitable for pulmonary drug delivery using carbon dioxide-assisted nebulization with a Bubble Dryer (CAN-BD).

机译:使用带有气泡干燥器(CAN-BD)的二氧化碳辅助雾化方法,可以生成和表征适合于肺部药物输送的细而稳定的粉末。

获取原文
获取原文并翻译 | 示例

摘要

Fine particles of a proteins, sugars, surfactants, and small molecule drugs, can be rapidly made by a new patented drying process, known as CO 2-Assisted Nebulization with a Bubble-DryerRTM (CAN-BD). The primary advantages of this process are that it facilitates drying of microbubbles and microdroplets at lower temperatures (25--65°C) than those used in traditional spray drying processes and that no organic solvents are required. The compound(s) of interest are dissolved in water or an appropriate organic solvent, and mixed intimately with near-critical or supercritical CO 2 by pumping both fluids through a low volume tee at room temperature and about 100 bar. The mixture is then decompressed through a 10.0 cm long, 75 micrometer inner diameter (i.d.) flow restrictor into a low temperature drying chamber. The aerosol plume is mixed with preheated nitrogen and is dried at temperatures between 30 and 60°C in less than 5 seconds near atmospheric pressure. These particles (hollow or solid) are generally formed in the optimum size range for pulmonary delivery to the alveoli (1 to 3 mum in diameter). Aerodynamic diameters were measured using the Model 3225 Aerosizer RTM DSP. The stability of the proteins was determined using spectroscopic enzymatic activity measurements and by analyzing the secondary structure using Fourier Transform Infrared Spectroscopy (FTIR). Differential scanning calorimetry (DSC) was performed on the dry powders to determine the glass transition temperatures (Tg) of the particles. The CAN-BD process did not cause detectable damage to the proteins studied. With the optimum combination of sugars with the protein, full enzymatic activity of the protein after redissolution was observed.; Particles can also be made from compounds that have limited or no significant solubility in water. The compound of interest can be dissolved in an appropriate organic solvent and dried by the CAN-BD process. Particles have successfully been made from compounds dissolved in methanol, ethanol, or acetone.; It is also possible to make particles of two compounds that are soluble in different solvents. By using a low dead volume mixing cross, two liquid streams can be intimately mixed with CO2, nebulized and dried to form heterogeneous particles.
机译:蛋白质,糖,表面活性剂和小分子药物的细颗粒可以通过一种获得专利的新型干燥工艺快速制成,该工艺称为带有Bubble-DryerRTM(CAN-BD)的CO 2辅助雾化。该方法的主要优点是与传统喷雾干燥工艺相比,它可以在较低的温度(25--65°C)下促进微泡和微滴的干燥,并且不需要有机溶剂。将所关注的化合物溶解于水或适当的有机溶剂中,并通过在室温和约100 bar下将两种流体泵入低体积的三通中,将它们与近临界或超临界CO 2紧密混合。然后将混合物通过10.0厘米长,内径为75微米(i.d.)的限流器减压进入低温干燥室。将气雾流与预热的氮气混合,并在30至60°C的温度下,在接近大气压的条件下不到5秒干燥。这些颗粒(空心或固体)通常在最佳尺寸范围内形成,以便肺部输送至肺泡(直径为1-3毫米)。使用3225型Aerosizer RTM DSP测量空气动力学直径。使用光谱酶活性测量并通过使用傅里叶变换红外光谱法(FTIR)分析二级结构来确定蛋白质的稳定性。对干粉进行差示扫描量热法(DSC),以确定颗粒的玻璃化转变温度(Tg)。 CAN-BD过程不会对所研究的蛋白质造成可检测的损害。通过糖与蛋白质的最佳组合,可以观察到重新溶解后蛋白质的全部酶活性。颗粒也可以由在水中具有有限的溶解度或没有显着溶解度的化合物制成。感兴趣的化合物可以溶解在适当的有机溶剂中,并通过CAN-BD工艺进行干燥。由溶解在甲醇,乙醇或丙酮中的化合物成功地制得了颗粒。还可以制备可溶于不同溶剂的两种化合物的颗粒。通过使用低死体积的混合叉,可以将两种液体流与CO2充分混合,雾化并干燥以形成异质颗粒。

著录项

  • 作者

    Villa, Joseph Anthony.;

  • 作者单位

    University of Colorado at Boulder.;

  • 授予单位 University of Colorado at Boulder.;
  • 学科 Chemistry Analytical.; Chemistry Pharmaceutical.
  • 学位 Ph.D.
  • 年度 2004
  • 页码 215 p.
  • 总页数 215
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 化学;药物化学;
  • 关键词

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号